Literature DB >> 11194796

Epidemiology of pneumococcal infections in Swedish children.

M Eriksson1, B Henriques, K Ekdahl.   

Abstract

OBJECTIVE: This paper provides an overview of pneumococcal infections in Swedish children.
METHOD: Data supplied by the Swedish Institute for Infectious Disease Control (SMI) provided information on invasive pneumococcal isolates and on isolates with reduced susceptibility to penicillin. Disease burden was estimated from data collected in northern Stockholm and Malmöhus County.
RESULTS: Only 3-6% of the total number of invasive pneumococcal isolates came from children 0-15 years of age. Predominant serotypes in descending frequency were 7, 6, 14, and 23. Strains from all sources with reduced sensitivity to penicillin (MIC > or = 0.5 mg/l) were found in 3% of children and varied between 0.2% and 11%, with the highest value found in Southern Sweden (predominating strains were 9, 19, 15, 6, and 23). A 10-year review of all cases of meningitis in Northern Stockholm reflected an incidence of 10/100,000 (0-2 years) or 5.8/100,000 (0-5 years), with severe sequelae occurring in 20% of children. This information can be used to predict an annual incidence of 30 cases of meningitis in Sweden.
CONCLUSION: The large proportion of serotype 7 among invasive isolates is distressing since this serotype is not represented in the present 7- and 9-valent protein-conjugated vaccines under development. However, the heptavalent vaccine, including serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F would (at a serotype level) provide coverage against 83% of the resistant isolates in Southern Sweden.

Entities:  

Mesh:

Year:  2000        PMID: 11194796     DOI: 10.1111/j.1651-2227.2000.tb00781.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  8 in total

Review 1.  The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity.

Authors:  Bertrand Boisson
Journal:  Hum Genet       Date:  2020-01-24       Impact factor: 4.132

2.  Burden of paediatric invasive pneumococcal disease in Europe, 2005.

Authors:  E D G McIntosh; B Fritzell; M A Fletcher
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

3.  IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.

Authors:  Cheng-Lung Ku; Capucine Picard; Melinda Erdös; Axel Jeurissen; Jacinta Bustamante; Anne Puel; Horst von Bernuth; Orchidée Filipe-Santos; Huey-Hsuan Chang; Tatiana Lawrence; Marc Raes; László Maródi; Xavier Bossuyt; Jean-Laurent Casanova
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

4.  Epidemiologic impact of blood culture practices and antibiotic consumption on pneumococcal bacteraemia in children.

Authors:  A Pérez; M Herranz; M Segura; E Padilla; F Gil; G Durán; F Ferres; A Esteve; D Blanquer; E Bernaola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-18       Impact factor: 3.267

5.  Antibiotic-resistant invasive pediatric Streptococcus pneumoniae clones in Israel.

Authors:  David Greenberg; Ron Dagan; Marie Muallem; Nurith Porat
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

6.  Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002.

Authors:  Kimiko Ubukata; Naoko Chiba; Keiko Hasegawa; Reiko Kobayashi; Satoshi Iwata; Keisuke Sunakawa
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005.

Authors:  C A Ihekweazu; D A B Dance; R Pebody; R C George; M D Smith; P Waight; H Christensen; K A V Cartwright; J M Stuart
Journal:  Epidemiol Infect       Date:  2007-10-26       Impact factor: 2.451

8.  Beta-lactamase-producing nontypeable Haemophilus influenzae fails to protect Streptococcus pneumoniae from amoxicillin during experimental acute otitis media.

Authors:  Eva Westman; Susanne Lundin; Ann Hermansson; Asa Melhus
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.